Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$9.55K Sell
248
-89
-26% -$3.74K 0.01% 499
2024
Q1
$14.4K Buy
337
+89
+36% +$3.67K ﹤0.01% 821
2023
Q4
$9.19K Buy
+248
New +$8.9K ﹤0.01% 891
2023
Q3
Sell
-360
Closed -$12.8K 628
2023
Q2
$12.8K Sell
360
-1,804
-83% -$64.7K ﹤0.01% 795
2023
Q1
$77K Hold
2,164
0.02% 394
2022
Q4
$76K Buy
+2,164
New +$72.1K 0.02% 419
2022
Q2
Sell
-4,109
Closed -$220K 389
2022
Q1
$220K Buy
+4,109
New +$223K 0.04% 345

Other funds holding GSK

ICA Group Wealth Management's GSK Position: Q2 2024 in Review

ICA Group Wealth Management reduced its GSK (GSK) stake by 26% in Q2 2024, selling an estimated $3.74K and leaving 248 shares worth $9.55K. The position accounts for 0.01% of the portfolio, ranked #499.

ICA Group Wealth Management first reported a position in GSK in Q1 2022 and has held it in 7 quarters since. The position peaked at $220K in Q1 2022. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • ICA Group Wealth Management held 248 shares of GSK worth $9.55K as of Q2 2024.
  • ICA Group Wealth Management sold 89 GSK shares in Q2 2024, an estimated $3.74K.
  • GSK made up 0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #499 holding.
  • ICA Group Wealth Management first reported a position in GSK in Q1 2022 and has held it in 7 quarters since.
  • ICA Group Wealth Management's GSK position peaked at $220K in Q1 2022.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.